Cited by 1,052Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesSmoking Behavior and Cessation

The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.

Mortality in COPD: role of comorbidities

Open access

Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G.·2006·European Respiratory Journal

DOI 10.1183/09031936.00133805

Open this paper in CoChat — free account Open PDF

Abstract

Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in advanced COPD. Comorbidities such as cardiovascular disease and lung cancer are also major causes and, in mild-to-moderate COPD, are the leading causes of mortality. The links between COPD and these conditions are not fully understood. However, a link through the inflammation pathway has been suggested, as persistent low-grade pulmonary and systemic inflammation, both known risk factors for cardiovascular disease and cancer, are present in COPD independent of cigarette smoking. Lung-specific measurements, such as forced expiratory volume in one second (FEV(1)), predict mortality in COPD and in the general population. However, composite tools, such as health-status measurements (e.g. St George's Respiratory Questionnaire) and the BODE index, which incorporates Body mass index, lung function (airflow Obstruction), Dyspnoea and Exercise capacity, predict mortality better than FEV(1) alone. These multidimensional tools may be more valuable because, unlike predictive approaches based on single parameters, they can reflect the range of comorbidities and the complexity of underlying mechanisms associated with COPD. The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructive pulmonary disease and comorbid conditions (i.e. inflammation), and the tools used to predict chronic obstructive pulmonary disease mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/09031936.00133805

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828

Show all 142 references

Research works printed but not linked: 11

1997, Monaldi Arch Chest Dis, 52, 43
1998, Monaldi Arch Chest Dis, 53, 324
1999, Eur Respir J, 14, 387s
10.1001/jama.1994.03520190043033 · DOI
2000, J Am Geriatr Soc, 48, S91
European Respiratory Society, European Lung Foundation. Loddenkemper R, Gibson GJ, Sibille Y, eds. Lung Health in Europe Facts and Figures. Sheffield, ERSJ, 2003; pp. 34–43
2004, Chest, 125, 134S
1998, Int J Mol Med, 2, 715
2001, Chest, 119, 1294
1995, Oncogene, 11, 999
1978, Scand J Respir Dis, 59, 154

Sorted by citations

Items 501–600 of 999

Using Cluster Analysis to Identify Phenotypes and Validation of Mortality in Men with COPD
Chen, C., Wang, L.-Y., Ou, C.-Y., Lee, C.-H., Lin, C., & Hsiue, T. (2014) · Lung · doi:10.1007/s00408-014-9646-x · Cited by 14
Comorbilidad, discapacidad y mortalidad en pacientes pluripatológicos con enfermedad pulmonar obstructiva crónica
Díez‐Manglano, J., Bernabeu‐Wittel, M., Escalera-Zalvide, A., Ledesma, M. S., Mora-Rufete, A., Nieto‐Martín, M. D., Barbé, J., & Moreno-Gaviño, L. (2011) · Revista Clínica Española · doi:10.1016/j.rce.2011.04.006 · Cited by 13
Anti-inflammatory effects of potato extract on a rat model of cigarette smoke–induced chronic obstructive pulmonary disease
Xu, G. H., Shen, J., Sun, P., Yang, M. L., Zhao, P., Niu, Y., Lu, J., Wang, Z. Q., Gao, C., Han, X. T., et al. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.28879 · Cited by 13
Prognostic value of cardiac troponin I during acute exacerbation of chronic obstructive pulmonary disease: A prospective study
Noorain, S. (2016) · Lung India · doi:10.4103/0970-2113.173052 · Cited by 13
La BPCO et la perception du nouveau document GOLD en Europe. Workshop de la Société de pneumologie de langue française (SPLF)
Zysman, M., Patout, M., Miravitlles, M., van der Molen, T., Løkke, A., Hausen, T., Didier, A. P., Cuvelier, A., & Roche, N. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.02.014 · Cited by 13
Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
Şerban, R. C., Hadadi, L., Şuş, I., Lakatos, É. K., Demjén, Z., & Scridon, A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.044 · Cited by 13
Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan
Lin, C.-H., Chen, K.-H., Chen, C., Chang, C., Huang, T., & Lin, C.-H. (2018) · PeerJ · doi:10.7717/peerj.4232 · Cited by 13
Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death – A National Register Study
Henoch, I., Ekberg‐Jansson, A., Löfdahl, C., & Strang, P. M. (2020) · International Journal of COPD · doi:10.2147/copd.s252709 · Cited by 13
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register
Arcoraci, V., Squadrito, F., Rottura, M., Barbieri, M. A., Pallio, G., Irrera, N., Nobili, A., Natoli, G., Argano, C., Squadrito, G., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.876693 · Cited by 13
Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
Sandelowsky, H., Janson, C., Wiklund, F., Telg, G., Licht, S. D. F., & Ställberg, B. (2022) · International Journal of COPD · doi:10.2147/copd.s372266 · Cited by 13
Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice?
Lusuardi, M., Garuti, G., Massobrio, M., Spagnolatti, L., & Bendinelli, S. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2008.406 · Cited by 13
Aortic calcification, arterial stiffness and bone mineral density in patients with COPD☆
Bolton, C. E., McEniery, C. M., Raj, V. J., McDonnell, B. J., Dixon, A. K., Munnery, M. M., Sabit, R., Screaton, N. J., Stone, M., Wilkinson, I. B., et al. (2011) · Artery Research · doi:10.1016/j.artres.2011.01.001 · Cited by 13
Exercise Limitation in Chronic Obstructive Pulmonary Disease
Laveneziana, P., Wadell, K., Webb, K. A., & O’Donnell, D. E. (2008) · Current Respiratory Medicine Reviews · doi:10.2174/157339808786263752 · Cited by 12
Predicting end-of-life in patients with an exacerbation of COPD by routine clinical assessment
Murphy, S. A., Mydin, H. H., Fatah, S., & Antunes, G. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.025 · Cited by 13
Nebulized formoterol: a review of clinical efficacy and safety in COPD
Gross, N. J. (2010) · International Journal of COPD · doi:10.2147/copd.s11006 · Cited by 13
Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care
Lari, S. M., Attaran, D., & Tohidi, M. R. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s54484 · Cited by 13
Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease
Khedoe, P. P. S. J., Rensen, P. C. N., Berbée, J. F. P., & Hiemstra, P. S. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00013.2016 · Cited by 15
Impaired training-induced adaptation of blood pressure in COPD patients: implication of the muscle capillary bed
Gouzi, F., Maury, J., Bughin, F., Blaquière, M., Ayoub, B., Mercier, J. G., Pérez‐Martin, A., Pomiès, P., & Hayot, M. (2016) · International Journal of COPD · doi:10.2147/copd.s113657 · Cited by 13
Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis – report from a population-based study
Sawalha, S., Hedman, L., Rönmark, E., Lundbäck, B., & Lindberg, A. (2017) · International Journal of COPD · doi:10.2147/copd.s127923 · Cited by 13
Anemia, hypoalbuminemia, and elevated troponin levels as risk factors for respiratory failure in patients with severe exacerbations of chronic obstructive pulmonary disease requiring invasive mechanical ventilation
Pavliša, G., Labor, M., Puretić, H., Hečimović, A., Jakopović, M., & Samaržija, M. (2017) · Croatian Medical Journal · doi:10.3325/cmj.2017.58.395 · Cited by 13
Increased serum levels of S100A1, ZAG, and adiponectin in cachectic patients with COPD
Mokari‐Yamchi, A., Sharifi, A., & Kheirouri, S. (2018) · International Journal of COPD · doi:10.2147/copd.s172996 · Cited by 13
Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review
Houben‐Wilke, S., Triest, F. J. J., Franssen, F. M. E., Janssen, D. J. A., Wouters, E. F. �., & Vanfleteren, L. E. G. W. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.2.2018.0145 · Cited by 13
Effectiveness of a Novel Qigong Meditative Movement Practice for Impaired Health in Flight Attendants Exposed to Second-Hand Cigarette Smoke
Payne, P., Fiering, S., Leiter, J. C., Zava, D. T., & Crane-Godreau, M. A. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00067 · Cited by 12
High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility
Graumam, R. Q., Pinheiro, M. A. A., Szejnfeld, V. L., Nery, L. E., & Castro, C. H. D. M. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06513-9 · Cited by 12
Systemic and Airway Epigenetic Disruptions Are Associated with Health Status in COPD
Cordero, A. I. H., Li, X., Yang, C. X., Yang, J., MacIsaac, J. L., Dever, K., Kobor, M. S., Milne, S. B., van Eeden, S. F., Shaipanich, T., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010134 · Cited by 11
GOLD severity stratification and risk of hospitalisation for COPD exacerbations
Lusuardi, M., Lucioni, C., Benedetto, F. D., Mazzi, S., Sanguinetti, C. M., & Donner, C. F. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2008.378 · Cited by 12
Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD
Urban, M. H., Valipour, A., Kiss, D. J., Eickhoff, P., Funk, G., & Burghuber, O. C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.03.013 · Cited by 12
Microalbuminuria in Subjects With COPD: Relationship to the New Version of Global Initiative for Chronic Obstructive Lung Disease Staging
Bozkuş, F., Dikmen, N., & Samur, A. A. (2016) · Respiratory Care · doi:10.4187/respcare.05168 · Cited by 12
Understanding racial differences of COPD patients with an ecological model: two large cohort studies in the US and Korea
Park, H. Y., Lee, H. J., Kang, D., Choi, H. S., Ryu, Y. H., Jung, K.-S., Sin, D. D., Cho, J., & Yoo, K. H. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320982455 · Cited by 12
Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease—A cross‐sectional study
Ljubičić, Đ., Balta, V., Dilber, D., Vražić, H., Đikić, D., Odeh, D., Habek, J. Č., Vukovac, E. L., & Tudorić, N. (2022) · Health Science Reports · doi:10.1002/hsr2.586 · Cited by 12
Pulmonary rehabilitation 2007: From bench to practice and back
Decramer, M. (2008) · Clinical and investigative medicine · doi:10.25011/cim.v31i5.4882 · Cited by 14
The Speed of Blood Pressure Fluctuations in Patients with Chronic Obstructive Pulmonary Disease
van Gestel, A. J. R., Clarenbach, C. F., Stöwhas, A.-C., Rossi, V. A., Sievi, N. A., Camen, G., & Kohler, M. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.08.010 · Cited by 12
Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: In vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups
Vandevelde, N. M., Tulkens, P. M., Iglesias, Y. D., Verhaegen, J., Rodriguez‐Villalobos, H., Philippart, I., Cadrobbi, J., Coppens, N., Boel, A., Vaerenbergh, K. V., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.016 · Cited by 12
One-year mortality after severe COPD exacerbation in Bulgaria
Mekov, E., Slavova, Y. G., Tsakova, A. D., Genova, M. P., Kostadinov, D., Minchev, D., Marinova, D., & Boyanov, M. (2016) · PeerJ · doi:10.7717/peerj.2788 · Cited by 12
Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease
Nilsson, U. A., Blomberg, A., Johansson, B. H., Bäckman, H., Eriksson, B., & Lindberg, A. (2017) · International Journal of COPD · doi:10.2147/copd.s136404 · Cited by 12
Effect of Dynamic Hyperinflation on Cardiac Response to Exercise of Patients With Chronic Obstructive Pulmonary Disease
Galera, R., Casitas, R., Martínez-Cerón, E., Rodríguez‐Fraga, O., Utrilla, C., Torres, I., Cubillos‐Zapata, C., & Rio, F. G. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2020.09.008 · Cited by 12
Emphysema on imaging is associated with quality of life in elderly patients with chronic obstructive pulmonary disease
Motohashi, N., Kimura, K., Ishii, T., Wakabayashi, R., Kurosaki, H., Motegi, T., Yamada, K., Jones, R. C. M., Gemma, A., & Kida, K. (2009) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2009.00549.x · Cited by 12
Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study
Vogelmeier, C. F., Friedrich, F. W., Timpel, P., Kossack, N., Diesing, J., Pignot, M., Abram, M., Gediga, M., & Halbach, M. (2025) · International Journal of COPD · doi:10.2147/copd.s488701 · Cited by 18
The influence of comorbidities on mortality in bronchiectasis: A prospective, observational study
Nowiński, A., Katarzyna, S., Maria, S., Michal, B., Robert, P., & Śliwiński, P. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/144200 · Cited by 11
The Effects of an Advanced Air Purification Technology on Environmental and Clinical Outcomes in a Long-Term Care Facility
Urrutia, A. R., Schlener, S., Eid, S. M., Bock, K. A., & Worrilow, K. C. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad113 · Cited by 11
The role of pulmonary vascular endothelium in chronic obstructive pulmonary disease (COPD): Does endothelium play a role in the onset and progression of COPD?
Siragusa, S., Natali, G., Nogara, A. M., Trevisani, M., Lagrasta, C. A. M., & Pontis, S. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00199 · Cited by 11
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
Wade, R. C., Martínez, F. J., Criner, G. J., Tombs, L., Lipson, D. A., Halpin, D. M. G., Han, M. K., Singh, D., Wise, R. A., Kalhan, R., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00171-2024 · Cited by 11
Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease
Cho, E. E., Maclagan, L. C., Chu, A., Croxford, R., Sin, D. D., Udell, J. A., Lee, D. S., Austin, P. C., & Gershon, A. S. (2025) · Thorax · doi:10.1136/thorax-2023-220991 · Cited by 11
Lung Ultrasound to Assess Pulmonary Congestion in Patients with Acute Exacerbation of COPD
Johannessen, Ø., Reite, F. U., Bhatnagar, R., Øvrebotten, T., Einvik, G., & Myhre, P. L. (2023) · International Journal of COPD · doi:10.2147/copd.s396855 · Cited by 12
Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome
Nguyen, B., Murphy, P. B., & Yee, B. J. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.04.003 · Cited by 12
Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease
Laforest, L., Licaj, I., Devouassoux, G., Hartwig, S., Marvalin, S., & Ganse, E. H. V. (2012) · Chronic Respiratory Disease · doi:10.1177/1479972312464245 · Cited by 11
Association between Airflow Limitation Severity and Arterial Stiffness as Determined by the Brachial-Ankle Pulse Wave Velocity: A Cross-Sectional Study
Oda, M., Omori, H., Onoue, A., Cui, X., Lu, X., Yada, H., Hisada, A., Miyazaki, W., Higashi, N., Ogata, Y., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3778 · Cited by 11
Blood Pressure Profile and Hypertensive Organ Damage in COPD Patients and Matched Controls. The RETAPOC Study
Golpe, R., Mateos-Colino, A., Testa-Fernández, A. M., Pena-Seijo, M., Rodríguez-Enríquez, M., González‐Juanatey, C., Martín-Vázquez, F. J., Pose‐Reino, A., Domínguez-Pin, N., Gayarre, N. G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157932 · Cited by 11
Do-not-resuscitate orders as part of advance care planning in patients with COPD
Raskin, J., Vermeersch, K., Everaerts, S., Bleyenbergh, P. V., & Janssens, W. (2018) · ERJ Open Research · doi:10.1183/23120541.00116-2017 · Cited by 11
Left heart function in COPD
Struß, N., Bauersachs, J. K., Welte, T., & Hohlfeld, J. M. (2019) · Herz · doi:10.1007/s00059-019-4816-5 · Cited by 11
Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease
Higuchi, S., Kohno, T., Kohsaka, S., Shiraishi, Y., Takei, M., Goda, A., Shoji, S., Nagatomo, Y., & Yoshikawa, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194378 · Cited by 11
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders
Arora, A., & Singh, A. (2023) · International Reviews of Immunology · doi:10.1080/08830185.2023.2222769 · Cited by 12
Burden of chronic obstructive pulmonary disease and its attributable risk factors in China from 1990 to 2021, with projections to 2050: an analysis of data from the Global Burden of Disease study 2021
Liu, M., Wei, S., Yang, X., Lu, Z., Zhang, W., Mensah, E., Zha, L., & Zhou, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1644022 · Cited by 10
Lung Cancer Risk in US Adults with COPD: A Systematic Review and Meta-Analysis
Obeng-Nyarkoh, P.-I., Valentin-Figueroa, M. E., Cadham, C. J., Cobb, N. K., Han, M. K., Levy, D. E., Meza, R., & Sánchez‐Romero, L. M. (2025) · International Journal of COPD · doi:10.2147/copd.s531972 · Cited by 11
Screening and impact of comorbidities in bronchiectasis: a forward-looking perspective
Angelis, A. D., Artuso, V. A., Aliberti, S., & Goeminne, P. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251390086 · Cited by 11
Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients
Lorenzana, I., Galera, R., Casitas, R., Martínez-Cerón, E., Castillo, M. A., Alfaro, E., Cubillos‐Zapata, C., & Rio, F. G. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107597 · Cited by 11
Modifiable risk factors that may be addressed in routine care to prevent progression to and extension of multimorbidity in people with COPD: a systematic literature review
Orlowski, A., Ettinger, J., Bottle, A., Snow, S. K., Ashton, R., & Quint, J. K. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002272 · Cited by 10
Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation
ter Haar, E. A. M. D., Slebos, D., Klooster, K., Pouwels, S. D., & Hartman, J. E. (2024) · ERJ Open Research · doi:10.1183/23120541.00268-2024 · Cited by 10
Burden of chronic obstructive pulmonary disease attributable to ambient ozone pollution across China and its provinces, 1990–2021: An analysis for the Global Burden of Disease Study 2021
Jiang, Y., Yan, F., Kan, H., Zhou, M., Yin, P., & Chen, R. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003415 · Cited by 10
Is inflammatory chronic obstructive pulmonary disease a coronary heart disease risk equivalent? A longitudinal analysis of the third National Health and Nutrition Examination Survey (NHANES III), 1988–1994
Parker, D. R., Liu, J., Roberts, M. B., & Eaton, C. B. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-195 · Cited by 10
Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease
Кароли, Н. А., & Rebrov, A. P. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.03.000061 · Cited by 10
Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study
Lei, Y.-F., Lin, H., Lin, H., Uang, Y. S., Cheng, H.-W., & Wang, L. (2020) · International Journal of COPD · doi:10.2147/copd.s267017 · Cited by 10
A few more steps lead to improvements in endothelial function in severe and very severe COPD
Kohlbrenner, D., Clarenbach, C. F., Thiel, S., Roeder, M., Kohler, M., & Sievi, N. A. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106246 · Cited by 11
Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital
Au, L., & Chan, H. (2013) · Hong Kong Medical Journal · doi:10.12809/hkmj133909 · Cited by 10
Impact of comorbidities in pulmonary rehabilitation outcomes in patients with COPD
Carreiro, A., Santos, J. V. D., & Rodrigues, F. (2013) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2012.12.001 · Cited by 13
Association of Airflow Limitation With Carotid Atherosclerosis in a Japanese Community ― The Hisayama Study ―
Kudo, K., Hata, J., Matsumoto, K., Shundo, Y., Fukuyama, S., Inoue, H., Kitazono, T., Kiyohara, Y., Ninomiya, T., & Nakanishi, Y. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1305 · Cited by 9
Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach
Boyer, L., Bastuji‐Garin, S., CHOUAID, C., HOUSSET, B., Corvoisier, P. L., Dérumeaux, G., Boczkowski, J., Maître, B., Adnot, S., & Audureau, É. (2018) · Scientific Reports · doi:10.1038/s41598-018-26766-x · Cited by 10
Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization
Oekelen, O. V., Vermeersch, K., Everaerts, S., Vandenberk, B., Willems, R., & Janssens, W. (2018) · International Journal of COPD · doi:10.2147/copd.s157630 · Cited by 10
Association between airflow limitation severity and reduced bone mineral density in Japanese men
Watanabe, K., Onoue, A., Kubota, K., Higashi, N., Hayashi, T., Tsuda, T., & Omori, H. (2019) · International Journal of COPD · doi:10.2147/copd.s213746 · Cited by 10
Chronic Obstructive Pulmonary Disease: A Complex Comorbidity of Lung Cancer
Grose, D. B., & Milroy, R. (2011) · Journal of Comorbidity · doi:10.15256/joc.2011.1.5 · Cited by 10
Life-course of cardio-respiratory associations
Eising, J. B., van der Ent, C. K., van der Gugten, A. C., Grobbee, D. E., Evelein, A. M. V., Numans, M. E., & Uiterwaal, C. S. P. M. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313510410 · Cited by 10
Factors Related to Microalbuminuria in Patients with Chronic Obstructive Pulmonary Disease
Kaysoydu, E., Arslan, S., Yıldız, G., & Candan, F. (2014) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/37236 · Cited by 10
Oxygen therapy in COPD patients with isolated nocturnal hypoxemia; comparison of quality of life and sleep between bronchitis and emphysema phenotype: A prospective observational study
Rizzi, M., Airoldi, A., Cristiano, A., Frassanito, F., Macaluso, C., Vanni, S., & Legnani, D. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.08.035 · Cited by 10
Heart-type fatty acid binding protein as a prognostic factor in patients with exacerbated chronic obstructive pulmonary disease
Sato, M., Inoue, S., Igarashi, A., Tokairin, Y., Sato, K., Nakano, H., Abe, Y., Kobayashi, M., Kimura, T., Yamauchi, K., et al. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.11.010 · Cited by 10
Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study
Takx, R. A. P., Vliegenthart, R., Hoesein, F. A. A. M., Išgum, I., de Koning, H. J., Mali, W. P. T. M., van der Aalst, C. M., Zanen, P., Lammers, J. J., Groen, H. J. M., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3384-6 · Cited by 10
Chronic Obstructive Pulmonary Disease
Stockley, R. A. (2001) · Wiley eBooks · doi:10.1038/npg.els.0002131 · Cited by 9
Adding biological markers to COPD categorisation schemes: a way towards more personalised care?
Roche, N. (2016) · European Respiratory Journal · doi:10.1183/13993003.00401-2016 · Cited by 9
Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort
Zou, R. H., Nouraie, M. S., Karoleski, C. M., Zhang, Y., Sciurba, F. C., Forman, D. E., & Bon, J. M. (2023) · Respiratory Research · doi:10.1186/s12931-023-02521-3 · Cited by 9
Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis
Gayen, S. K., Zulty, M., & Criner, G. J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02674-9 · Cited by 9
Analysis of Risk Factors for COPD Incidence in Adults Over 40 Years of Age in Korea
Lee, D. (2024) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2024.19.1.23 · Cited by 9
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study
Shrikrishna, D., Steer, J., Bostock, B., Dickinson, S., Piwko, A., Ramalingam, S., Saggu, R., Stonham, C., Storey, R. F., Taylor, C. J., et al. (2025) · International Journal of COPD · doi:10.2147/copd.s523865 · Cited by 9
Vitamin D and Chronic Obstructive Pulmonary Disease
Janssens, W., Lehouck, A., Decramer, M., & Gayan‐Ramirez, G. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-888-7_11 · Cited by 9
Effects of Inhaled Tiotropium on Left Ventricular Diastolic Function in Chronic Obstructive Pulmonary Disease Patients after Pulmonary Resection
Nojiri, T., Yamamoto, K., Maeda, H., Takeuchi, Y., Funakoshi, Y., Maekura, R., & Okumura, M. (2012) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.11.01787 · Cited by 9
Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma
Gagnat, A. A., Gjerdevik, M., Lie, S. A., Gulsvik, A., Bakke, P. S., & Nielsen, R. (2020) · European Clinical Respiratory Journal · doi:10.1080/20018525.2020.1799540 · Cited by 9
Obstructive lung disease in acute medical patients.
Seemungal, T., Harrinarine, R., Rios, M., Abiraj, V., Ali, A., Lacki, N., Mahabir, N., Ramoutar, V. R. N., King, C. P., Bhowmik, A., et al. (2008) · PubMed · Cited by 9
Factors associated with the incidence of serious adverse events in patients admitted with COPD acute exacerbation
García-Sanz, M.-T., Cánive-Gómez, J.-C., García-Couceiro, N., Senín-Rial, L., Alonso-Acuña, S., Barreiro-García, A., López-Val, E., Valdés, L., & González‐Barcala, F. J. (2016) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1431-9 · Cited by 9
Assessment of osteoporosis using the FRAX method and the importance of vitamin D levels in COPD patients
Anar, C. M., Yavuz, M. Y., Güldaval, F., Varol, Y., & Kalenci, D. (2018) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-017-0116-1 · Cited by 9
Study of microalbuminuria in chronic obstructive pulmonary disease patients at tertiary care teaching hospital
Gupta, K., Kotwal, M., Atam, V., Usman, K., Sc, C., & Kumar, A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_327_20 · Cited by 9
Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin ‘never means nothing’
Hinton, J., Gabara, L., & Curzen, N. P. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1828063 · Cited by 9
Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case–control study
Hu, W., Lhamo, T., Zhang, F., Hang, J., Zuo, Y.-H., Hua, J.-L., Li, S., & Zhang, J. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01803-8 · Cited by 9
Effect of COPD on the Hospital Outcomes and Mortality among Hemorrhagic Stroke Patients. Sex Differences in a Population-Based Study
de Miguel‐Díez, J., López‐Herránz, M., Jiménez-García, R., Hernández‐Barrera, V., Jiménez‐Trujillo, I., de Miguel-Yanes, J. M., & López‐de‐Andrés, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112491 · Cited by 9
Sex Differences in the Incidence and Outcomes of COPD Patients Hospitalized with Ischemic Stroke in Spain: A Population-Based Observational Study
de Miguel‐Díez, J., López‐de‐Andrés, A., Jiménez‐García, R., Hernández‐Barrera, V., Jiménez‐Trujillo, I., Ji, Z., de Miguel-Yanes, J. M., & López‐Herránz, M. (2021) · International Journal of COPD · doi:10.2147/copd.s311826 · Cited by 9
Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD
Mitzel, H., Brown, D., Thomas, M., Curl, B., Wild, M., Kelsch, A. V., Muskrat, J., Hossain, A., Ryan, K., Babalola, O., et al. (2022) · Medicina · doi:10.3390/medicina58020254 · Cited by 9
Carotid intima-media thickness in patients with chronic obstructive pulmonary disease
Pobeha, P., Skyba, P., Joppa, P., Kluchová, Z., Szabóová, E., Tkac, I., & Tkacova, R. (2011) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657567 · Cited by 9
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance
Pleasants, R. A., Heidari, K., Wheaton, A. G., Ohar, J. A., Strange, C., Croft, J. B., Liao, W., Mannino, D. M., & Kraft, M. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1043424 · Cited by 9
Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease
Lacoma, A., Prat, C., Andreo, F., Lores, L., Latorre, I., Pérez, M., Manzano, J. R., Ausina, V., & Domínguez, J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.032 · Cited by 9
Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice
Luijks, H., Grauw, W. J. D., Bor, J. H., van Weel, C., Lagro-Janssen, A. L. M., Biermans, M. C. J., & Schermer, T. R. (2015) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2015.32 · Cited by 9
Pathogenesis and pathophysiology of COPD
Yoo, C. G. (2009) · The Korean Journal of Internal Medicine · Cited by 8
A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study
Nishida, Y., Takahashi, Y., Tezuka, K., Yamazaki, K., Yada, Y., Nakayama, T., & Asai, S. (2017) · International Journal of COPD · doi:10.2147/copd.s138103 · Cited by 10
Competitive interaction between chronic obstructive pulmonary disease and CHA 2 DS 2 -VASc score in predicting incident atrial fibrillation
Perticone, M., Sciacqua, A., Tripepi, G. L., Miceli, S., Corrao, S., Sesti, G., & Perticone, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.036 · Cited by 9

Authors: Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G.
Affiliations: St. Paul's Hospital (CA)
London School of Hygiene & Tropical Medicine (GB)
ORCID: Sin, D. D.
Soriano, J. B.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2006-11-30
Volume: 28
Issue: 6
Pages: 1245-1257
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00133805
OpenAlex: W2118228748
Cited by: 1,052
References: 142
Citations by year: 2026: 22 · 2025: 44 · 2024: 43 · 2023: 40 · 2022: 36 · 2021: 60 · 2020: 61 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 76 · 2015: 61 · 2014: 77 · 2013: 74 · 2012: 51
FWCI: 7.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Funders: AstraZeneca
GlaxoSmithKline
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: chronic obstructive pulmonary disease, COPD mortality, comorbidities, cardiovascular disease, lung cancer, low-grade inflammation, respiratory failure, FEV1, BODE index, St George's Respiratory Questionnaire, mortality prediction, health assessment
MeSH terms: Health Status, Humans, Comorbidity, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mortality in COPD: role of comorbidities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks